These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
552 related items for PubMed ID: 19686743
1. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis. Calvisi DF, Ladu S, Pinna F, Frau M, Tomasi ML, Sini M, Simile MM, Bonelli P, Muroni MR, Seddaiu MA, Lim DS, Feo F, Pascale RM. Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743 [Abstract] [Full Text] [Related]
2. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1). Zhao Y, Tang Q, Ni R, Huang X, Wang Y, Lu C, Shen A, Wang Y, Li C, Yuan Q, Chen H, Cheng C, He S. Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332 [Abstract] [Full Text] [Related]
3. Cell-cycle regulator Cks1 promotes hepatocellular carcinoma by supporting NF-κB-dependent expression of interleukin-8. Lee EK, Kim DG, Kim JS, Yoon Y. Cancer Res; 2011 Nov 01; 71(21):6827-35. PubMed ID: 21917729 [Abstract] [Full Text] [Related]
4. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. Bashir T, Dorrello NV, Amador V, Guardavaccaro D, Pagano M. Nature; 2004 Mar 11; 428(6979):190-3. PubMed ID: 15014502 [Abstract] [Full Text] [Related]
5. TGF-β activates APC through Cdh1 binding for Cks1 and Skp2 proteasomal destruction stabilizing p27kip1 for normal endometrial growth. Pavlides SC, Lecanda J, Daubriac J, Pandya UM, Gama P, Blank S, Mittal K, Shukla P, Gold LI. Cell Cycle; 2016 Mar 11; 15(7):931-47. PubMed ID: 26963853 [Abstract] [Full Text] [Related]
10. Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells. Motomura W, Takahashi N, Nagamine M, Sawamukai M, Tanno S, Kohgo Y, Okumura T. Int J Cancer; 2004 Jan 01; 108(1):41-6. PubMed ID: 14618613 [Abstract] [Full Text] [Related]
12. Oncostatin M induces growth arrest by inhibition of Skp2, Cks1, and cyclin A expression and induced p21 expression. Halfter H, Friedrich M, Resch A, Kullmann M, Stögbauer F, Ringelstein EB, Hengst L. Cancer Res; 2006 Jul 01; 66(13):6530-9. PubMed ID: 16818624 [Abstract] [Full Text] [Related]
14. Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study. Liu Z, Fu Q, Lv J, Wang F, Ding K. J Exp Clin Cancer Res; 2008 Oct 15; 27(1):51. PubMed ID: 18922157 [Abstract] [Full Text] [Related]
17. Structural basis of the Cks1-dependent recognition of p27(Kip1) by the SCF(Skp2) ubiquitin ligase. Hao B, Zheng N, Schulman BA, Wu G, Miller JJ, Pagano M, Pavletich NP. Mol Cell; 2005 Oct 07; 20(1):9-19. PubMed ID: 16209941 [Abstract] [Full Text] [Related]
18. Cks1 regulates human hepatocellular carcinoma cell progression through osteopontin expression. Kang YS, Jeong EJ, Seok HJ, Kim SK, Hwang JS, Choi ML, Jo DG, Kim Y, Choi J, Lee YJ, Jung E, Min JK, Han TS, Kim JS. Biochem Biophys Res Commun; 2019 Jan 01; 508(1):275-281. PubMed ID: 30497779 [Abstract] [Full Text] [Related]